|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0011860,
umls-concept:C0017725,
umls-concept:C0023791,
umls-concept:C0028754,
umls-concept:C0030705,
umls-concept:C0086045,
umls-concept:C0087111,
umls-concept:C0229671,
umls-concept:C0244104,
umls-concept:C0332161,
umls-concept:C0332307,
umls-concept:C0376261,
umls-concept:C0547047,
umls-concept:C1280519,
umls-concept:C2709063
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1999-7-9
|
|
pubmed:abstractText |
We examined the effect of lipoic acid (LA), a cofactor of the pyruvate dehydrogenase complex (PDH), on insulin sensitivity (SI) and glucose effectiveness (SG) and on serum lactate and pyruvate levels after oral glucose tolerance tests (OGTTs) and modified frequently sampled intravenous glucose tolerance tests (FSIGTTs) in lean (n = 10) and obese (n = 10) patients with type 2 diabetes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0149-5992
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
22
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
280-7
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10333946-Blood Glucose,
pubmed-meshheading:10333946-Diabetes Mellitus,
pubmed-meshheading:10333946-Diabetes Mellitus, Type 2,
pubmed-meshheading:10333946-Fasting,
pubmed-meshheading:10333946-Glucose Tolerance Test,
pubmed-meshheading:10333946-Hemoglobin A, Glycosylated,
pubmed-meshheading:10333946-Humans,
pubmed-meshheading:10333946-Hyperglycemia,
pubmed-meshheading:10333946-Insulin,
pubmed-meshheading:10333946-Lactates,
pubmed-meshheading:10333946-Middle Aged,
pubmed-meshheading:10333946-Obesity,
pubmed-meshheading:10333946-Pyruvates,
pubmed-meshheading:10333946-Reference Values,
pubmed-meshheading:10333946-Thinness,
pubmed-meshheading:10333946-Thioctic Acid,
pubmed-meshheading:10333946-Time Factors,
pubmed-meshheading:10333946-Triglycerides
|
|
pubmed:year |
1999
|
|
pubmed:articleTitle |
alpha-Lipoic acid treatment decreases serum lactate and pyruvate concentrations and improves glucose effectiveness in lean and obese patients with type 2 diabetes.
|
|
pubmed:affiliation |
Department of Internal Medicine, J.W. Goethe-University, Frankfurt, Germany.
|
|
pubmed:publicationType |
Journal Article
|
